Synthesis and Antibacterial Activity Evaluation of Novel (E)‐4‐(4‐((arylidene)amino)phenoxy)coumarin Derivatives

A series of novel ( E )‐4‐(4‐((arylidene)amino)phenoxy)coumarin derivatives were synthesized from 4‐hydroxycoumarin in three step reactions, and their antibacterial activities against Xanthomonas oryzae pv. oryzae (Xoo ) and Xanthomonas citri subsp. Citri (Xcc ) in vitro were evaluated. Result found that most of the target compounds exhibited pronounced antibacterial activities. Among the target compounds, 3f , 3g , 3h , 3i , 3j , 3n , 3o , and 3p exhibited excellent antibacterial activities against Xoo , with EC₅₀ values of 143.9, 127.4, 133.8, 145.8, 138.4, 116.9, 134.6, and 121.8 µg/mL, respectively, which were better than that of thiadiazole copper (203.6 µg/mL). Moreover, compounds 3f , 3g , 3h , 3i , 3j , 3n , 3o , and 3p showed good antibacterial activities against Xcc , with EC₅₀ values of 118.4, 126.3, 117.2, 105.3, 102.3, 95.2, 96.0, and 88.2 µg/mL, respectively, which were similar to that of thiadiazole copper (138.3 µg/mL).